Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction

Myrielle Mathieu, J. Bartunek, B. Oumeiri, El, K. Touihri, I. Hadad, Philippe Thoma, T. Metens, A.M. Costa, da, M. Mahmoudabady, D. Egrise, D. Blocklet, N. Mazouz, R. Naeije, G.R. Heyndrickx, K. McEntee

Research output: Contribution to journalArticleAcademicpeer-review

44 Citations (Scopus)
1 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction'. Together they form a unique fingerprint.

Medicine & Life Sciences